Resultados de la búsqueda 241-250 of 4895 for Two-phase
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Most treatments are given every 2 to 3 weeks, depending on the medicines used. A common first line chemotherapy treatment combination includes 5 ...
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...
... two previously validated quality-of-life scales. ... (Stage I and Stage II). Additinoally, to evaluate ... (Stage I and Stage II). Additinoally, to ...
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
... phase II dose (RP2D of APG2575 in combination ... (2) Cohort 2 focuses on primary or secondary ... Patients will be randomized 1:1 into the two arms.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
More than two thirds of affected infants have ... This phase II trial studies how well inotuzumab ... Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?